Linearis, avec son tandem de fonds de capital de risque et de laboratoire, soutient les découvertes visant à prévenir, détecter et guérir les maladies grâce à des investissements directs dans des entreprises innovantes en AI appliquées aux sciences de la vie.

Rapide
Précis
Accessible

Réponse prédictive

Traitement personnalisé

Boucle de rétroaction de l’IA pour des traitements curatifs
NOETIK is a frontier therapeutics company harnessing AI to deeply understand human biology and redefine clinical outcomes in oncology. Leveraging the largest proprietary multimodal oncology dataset of its kind, uniquely integrating spatial biology. Find out more at www.noetik.ai
Feldan is a clinical-stage biotech company specializing in the development of treatments based on the intracellular delivery of therapeutics with a proprietary peptide-based technology ensuring safe, rapid, and efficient local delivery of antisense oligonucleotides to cells. Find out more at www.feldan.com
Zilia is measuring non-invasively the eyes by integrating advanced photonics and artificial intelligence to leverage direct connections between the eye biomarkers, the vascular system, the brain and overall health. Find out more at www.zilia.com